Plant Summary
Plant Information
TCMBank_ID: | TCMBANKHE008735 |
ID: | TCMBANKHE008735 |
植物拉丁名: |
|
功能与主治: | To quicken blood and dissipate stasis, dispel wind and eliminate damp, move qi and relieve pain./Menstrual disorder, dysmenorrhea, postpartum blood stasis abdominal pain, cold pain in stomach duct and abdomen, knocks and falls, wind-damp impediment pain. |
药用植物名: | 红毛七 |
药用部位: | root and rhizome |
TCM_ID_id: | 996 |
植物对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
| TCMBANKIN000046 | theanine | C7H14N2O3 | 174.2 g/mol | CCNC(=O)CCC(C(=O)O)N | |
| TCMBANKIN000494 | cauloside c | C41H66O13 | 767 g/mol | CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)CO)OC6C(C(C(CO6)O)O)OC7C(C(C(C(O7)CO)O)O)O)C)C)C2C1)C)C(=O)O)C | |
| TCMBANKIN000635 | sparteine | EBD2202131; DSSTox_CID_3591; 298897D62S; AK122435; NCGC00142614-01; 90-39-1; RL05684; (7S,7aS,14S,14aR)-dodecahydro-7,14-methano-2H,6H-dipyrido[1,2-a:1',2'-e][1,5]diazocine; L-SPARTEINE; Ambotz90-39-1; Sparteina; 7,14-methano-2H,6H-dipyrido[1,2-a:1',2'-e][1,5]diazocine, dodecahydro-, (7S,7aR,14S,14aS)-; C10783; InChI=1/C15H26N2/c1-3-7-16-11-13-9-12(14(16)5-1)10-17-8-4-2-6-15(13)17/h12-15H,1-11H2/t12?,13?,14-,15-/m0/s; (7S,7aR,14S,14aS)-Dodecahydro-7,14-methano-2H,6H-dipyrido[1,2-a:1',2'-e][1,5]diazocine; Esparteina; CAS-90-39-1; ST24033390; TL8005816; Spartein; ZINC1408502; AJ-67273; CS-W012901; Alkyl Polyglucoside; KS-00000OBL; Sparteinum; UNII-298897D62S; 6-beta,7-alpha,9-alpha,11-alpha-Pachycarpine; MLS002207055; KB-209108; CHEMBL1908847; 7,14-Methano-2H,6H-dipyrido(1,2-a:1',2'-e)(1,5)diazocine, dodecahydro-, (7S-(7alpha,7aalpha,14alpha,14abeta))-; AC1LVZQY; Sparteinum [INN-Latin]; Alkylamphopropionate; 7,14-Methano-2H,6H-dipyrido[1,2-a:1',2'-e][1,5]diazocine, dodecahydro-, [7S-(7alpha,7aalpha,14alpha,14abeta)]-; AKOS016012217; FT-0080874; 6beta,7alpha,9alpha,11alpha-Pachycarpine; Sparteine (-); (6''R'',8''S'',10''R'',12''S'')-7,15-diazatetracyclo[7.7.1.02,7.010,15]heptadecane; MLS000028889; NCGC00181124-02; (-)-Sparteine, >=98.0% (GC); Sparteina [DCIT]; Esparteina [INN-Spanish]; 7,14-Methano-2H,6H-dipyrido(1,2-a:1',2'-e)(1,5)diazocine, dodecahydro-; Sparteine [INN]; CHEBI:28827; (+)-Spartein; DSSTox_RID_77098; DSSTox_GSID_23591; (-)sparteine; Prestwick3_000618; lupinidine; 7,14-Methano-2H,6H-dipyrido[1,2-a:1',2'-e][1,5]diazocine,dodecahydro-, (7S,7aR,14S,14aS)-; SCHEMBL79043; (-)-Sparteine; [7S-(7alpha,7aalpha,14alpha,14abeta)]-Dodecahydro-7,14-methano-2H,6H-dipyrido[1,2-a:1',2'-e][1,5]diazocine; BPBio1_000612; Prestwick_426; (-)-Lupinidine; HMS2096L18; (-) sparteine; Sparteine; (7S,7aR,14S,14aS)-Tetradecahydro-7,14-methanodipyrido[1,2-a:1',2'-e][1,5]diazocine; Lupinidin; NCGC00016346-01; SMR000059203; Tox21_110386_1; EINECS 201-988-8; Genisteine Alkaloid; Sparteine (6CI,8CI); BSPBio_000556; SLRCCWJSBJZJBV-ZQDZILKHSA-N; Tox21_110386; AC1LD8G5 | C15H26N2 | 234.38 g/mol | C1CCN2CC3CC(C2C1)CN4C3CCCC4 |
| TCMBANKIN006687 | Thalictroidine | C14H19NO2 | 233.31 g/mol | CN1CCCCC1CC(=O)C2=CC=C(C=C2)O | |
| TCMBANKIN008766 | 3,4,5-trimethoxy-7,8-dimethoxy isoflavanone | ||||
| TCMBANKIN009190 | lupenone | lupenone ; 1617-70-5; LUPENONE; SCHEMBL1483620; NSC 281807; ZINC04081760; Lup-20(29)-en-3-one (8CI)(9CI); (1R,3aR,4S,5aR,5bR,7aR,11aR,11bR,13aR,13bR)-1-Isopropenyl-3a,5a,5b,8,8,11a-hexamethyl-eicosahydro-cyclopenta[a]chrysen-9-one; AIDS-082905; AIDS082905 | C30H48O | 424.7 g/mol | CC(=C)C1CCC2(C1C3CCC4C5(CCC(=O)C(C5CCC4(C3(CC2)C)C)(C)C)C)C |
| TCMBANKIN013520 | cauloside b | C35H56O9 | 620.8 g/mol | CC1(CCC2(C(C1)C3=CCC4C5(CCC(C(C5CCC4(C3(CC2O)C)C)(C)CO)OC6C(C(C(CO6)O)O)O)C)C(=O)O)C | |
| TCMBANKIN020272 | α-isolupanine | ||||
| TCMBANKIN021571 | 16α-hydroxy-olean-12-en-28 oic acid-3-O-α-L-arabinopyranoside | C20H32O3 | |||
| TCMBANKIN027132 | 16α,23,28-trihydroxy-olean-12-en-3-O-α-L-arabinopyranoside | ||||
| TCMBANKIN028028 | caulophyllogenin-3-O-α-L-arabinopyranoside | ||||
| TCMBANKIN028081 | α-spinasteryl-3-O-β-D-glucoside | ||||
| TCMBANKIN031837 | cayratinin | C42H47ClO24 | C1=CC(=CC=C1C=CC(=O)OC2C(C(OC(C2O)OC3C(C(C(OC3OC4=C([O+]=C5C=C(C=C(C5=C4)OC6C(C(C(C(O6)CO)O)O)O)O)C7=CC(=C(C(=C7)O)O)O)CO)O)O)CO)O)O.[Cl-] | ||
| TCMBANKIN036001 | echinocysticacid-3-O-α-L-arabinopyranoside | ||||
| TCMBANKIN036252 | hederagenin-3-O-β-D-glucopyranosyl-(1→2)-α-L-arabinopyranoside | ||||
| TCMBANKIN057998 | magnoflorine | NSC150447; AKOS025401511; Magnoflorine; Escholine Iodide; C20H24NO4.I; Magnoflorine, iodide; Thalictrine Iodide; Magnoflorine Iodide (6CI,7CI); N2506; AC-20269; 4H-Dibenzo(de,g)quinolinium, 5,6,6a,7-tetrahydro-1,11-dihydroxy-2,10-dimethoxy-6,6-dimethyl-, iodide, (S)-; Magnoflorine-iodide; NSC 150447; MAGNOFLORINE IODIDE; MAGNOFLORINE IODIDE, (+)-(RG); Magnoflorineiodide; BG01755204; (+)-Magnoflorine Iodide; CHEMBL494052; Corytuberine Methiodide; MolPort-006-069-296; NSC-150447; 4277-43-4; (+)-MAGNOFLORINE IODIDE; 1,11-Dihydroxy-2,10-dimethoxy-6-methyl-6a; AK608288; A-aporphinium Iodide; 8167AH; DTXSID00195420; (6aS)-5,6,6a,7-Tetrahydro-1,11-dihydroxy-2,10-dimethoxy-6,6-dimethyl-4H-dibenzo[de,g]quinolinium Iodide; magnoflorine; (+)-magnoflorine | C20H24NO4+ | 342.4 g/mol | C[N+]1(CCC2=CC(=C(C3=C2C1CC4=C3C(=C(C=C4)OC)O)O)OC)C |
| TCMBANKIN058626 | lupanine | lupaninium; CHEBI:64261; 2-oxospartein-16-ium; lupanine(1+);(+)-Lupanine;C10772; 550-90-3 | C15H24N2O | 248.36 g/mol | C1CCN2CC3CC(C2C1)CN4C3CCCC4=O |
| TCMBANKIN058704 | lupeol | AC-1371; AKOS015960466; SCHEMBL14067725; 4CN-0933; C08628; BC201808; Lup-20(29)-en-3.beta.-ol; NSC90487; ZINC04081455; D0RA6H; Lupeol; LMPR01060013; lupeol ; Monogynol B; .beta.-Viscol; NCI60_042005; lup-20(29)-en-3beta-ol; Lupenol | C30H50O | 426.7 g/mol | CC(=C)C1CCC2(C1C3CCC4C5(CCC(C(C5CCC4(C3(CC2)C)C)(C)C)O)C)C |
| TCMBANKIN059249 | CLR | 5-Cholesten-3b-ol; Hydrocerin; 5:6-Cholesten-3beta-ol; 209124-38-9; Lidinite; 5:6-Cholesten-3.beta.-ol; Tegolan (VAN); C1231_SIGMA; 3-beta-Hydroxycholest-5-ene; Delta5-Cholesten-3beta-ol; C3292_SIGMA; (3H)-Cholesterol; 20808_RIEDEL; S5442_SIGMA; Cholest-5-en-3-ol, (3-.beta.)-; Super hartolan; Cholesterol (JP15/NF); AIDS338945; 5:6-Cholesten-3-ol; nchembio782-comp1; 3beta-Hydroxy-5-cholestene; delta(sup 5)-Cholesten-3-beta-ol; Dusoline; CHOLESTEROL; D00040; C00187; Provitamin D; Wool alcohols B. P.; Cholest-5-en-3-ol, (3beta)-; Synthetic cholesterol; Dythol; CMC_13392; HSDB 7106; 3beta-Hydroxycholest-5-ene; Cordulan; 5,6-Cholesten-3.beta.-ol; Cholest-5-en-3.beta.-ol; 57-88-5; Kathro; Dusoran; (3beta)-cholest-5-en-3-ol; WLN: L E5 B666 LUTJ A1 E1 FY1&3Y1&1 OQ; 3.beta.-Hydroxycholest-5-ene; 26740_FLUKA; Cholesterol base H; Cholest-5-en-3-ol (3beta)-, labeled with tritium; NCGC00159351-02; 80356-14-5; Cholest-5-en-3-ol, (3.beta.)-; Cholestrin; 5-Cholesten-3beta-ol; ZINC03875383; 218965-24-3; 26732_FLUKA; Cholesterin; C8667_SIGMA; 22243-67-0; Lidinit; Phospholipon & Cholesterol; CHEBI:16113; SyntheChol NS0 Supplement; NSC 8798; nchembio.77-comp1; AI3-03112; Lanol; Cholestrol; AIDS080405; Cholest-5-en-3-ol (3beta)-; 5-Cholesten-3.beta.-ol; SyntheChol; NSC8798; Cholesterol solution; Cholesterol [USAN:JAN]; Nimco cholesterol base H; C8503_SIGMA; BB_NC-0135; SMP1_000069; C3137_SIGMA; Cholesterine; 47127U_SUPELCO; Cholest-5-en-3-beta-ol; Nimco cholesterol base No. 712; AIDS-338945; Cholesteryl alcohol; C3045_SIGMA; 14606_FLUKA; Soya phospholipon & Cholesterol (2:1 molar ratio); AIDS-080405; LMST01010001; CCRIS 2834; (3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol; Cholest-5-en-3beta-ol; Cholesterol (TN); EINECS 200-353-2; Tegolan;cholesterol;8(14)-dehydrocholesterol; 177962-82-2; SCHEMBL5347436; cholesta-5,8(14)-dien-3beta-ol; DJNCIOAUQVURTQ-RQZUOROGSA-N | C27H46O | 386.65 | CC(C)CCCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C |
| TCMBANKIN059631 | Cauloside A | C35H56O8 | 604.8 g/mol | CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)CO)OC6C(C(C(CO6)O)O)O)C)C)C2C1)C)C(=O)O)C | |
| TCMBANKIN060228 | clematibetoside c | C53H86O22 | 1075.39g/mol | CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OCC3C(C(C(C(O3)OC(=O)C45CCC(CC4C6=CCC7C8(CCC(C(C8CCC7(C6(CC5)C)C)(C)CO)OC9C(C(C(CO9)O)O)O)C)(C)C)O)O)O)CO)O)O)O | |
| TCMBANKIN060679 | stigmasterol | C29H48O | 412.7 g/mol | CCC(C=CC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C)C(C)C | |
| TCMBANKIN061811 | Demethoxyyangonin | 4-methoxy-6-[(E)-2-phenylethenyl]pyran-2-one; NCGC00091904-01; Desmethoxyyangonin; 15345-89-8; AIDS-224739; NSC 112161; 26531-51-1; 4-methoxy-6-[(E)-2-phenylvinyl]-2-pyranone; NSC112161; 4-methoxy-6-(2-phenylvinyl)pyran-2-one; 2H-Pyran-2-one, 4-methoxy-6-[(E)-2-phenylethenyl]-; 4-methoxy-6-(2-phenylvinyl)-2-pyranone; 2H-Pyran-2-one, 4-methoxy-6-styryl-, (E)-; 2H-Pyran-2-one, 4-methoxy-6-(2-phenylethenyl)-, (E)- (9CI); (E)-4-Methoxy-6-(2-phenylethenyl)-2H-pyran-2-one; 4-methoxy-6-(2-phenylethenyl)pyran-2-one; C09925; 4-Methoxy-6-styryl-2H-pyran-2-one; 4-methoxy-6-[(E)-2-phenylvinyl]pyran-2-one; NSC68686; 1952-41-6; 5,6-Dehydrokawain; 4-methoxy-6-[(E)-2-phenylvinyl]-2H-pyran-2-one; demethoxyyangonin; AIDS224739; 2H-Pyran-2-one, 4-methoxy-6-(2-phenylethenyl)-;5,6-dehydrokawain;5,6-dehydrokawain | C14H12O3 | 228.24 g/mol | COC1=CC(=O)OC(=C1)C=CC2=CC=CC=C2 |
| TCMBANKIN061955 | taspine | thaspine | C20H19NO6 | 369.37 | CN(C)CCC1=CC(=C2C3=C1C(=O)OC4=C(C=CC(=C34)C(=O)O2)OC)OC |
植物对应的疾病
| 疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
|---|
植物对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 | 染色体位置 | Map_Location | 基因类型 |
|---|
滇ICP备16009434号-1 |
Dai SX Lab